Neoadjuvant Docetaxel in Breast Cancer: 3-Year Survival Results from the Aberdeen Trial
Year: 2002
Type: article
Study design: Clinical Trial
Source: Clinical Breast Cancer
Authors: Steven D. Heys, Andrew W. Hutcheon, Tarun K. Sarkar, Keith N. Ogston, Iain D. Miller, Simon Payne, Ian Smith, Leslie G. Walker, Oleg Eremin
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2055679225
